MCD vs STRO
McDonald’s Corporation (MCD) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
MCD currently screens at market cap $201.66B and trailing P/E 23.4. STRO currently screens at market cap $470.8M.
Not investment advice. Open the MCD and STRO stock pages for the full models.
Not investment advice.